About Neuralynx
Neuralynx is a company based in Bozeman (United States) founded in 1993 by Casey Stengel was acquired by FHC in December 2021. The company has 17 employees. Neuralynx offers products and services including Digital Lynx +, Research Software, and ATLAS Neurophysiology System. Neuralynx operates in a competitive market with competitors including Cepheid, Esco Lifesciences, Beckman Coulter, Blackrock Neurotech and Fluidigm, among others.
Products & Services of Neuralynx
Neuralynx offers a comprehensive portfolio of products and services, including Digital Lynx +, Research Software, and ATLAS Neurophysiology System.
High-performance system for multichannel neural recording in research.
Tools for experiment control and neural data processing applications.
Integrated system for human single unit recording in clinical settings.
Investors in Neuralynx
Neuralynx has secured backing from 1 investor. Prominent investors backing the company include FHC.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Precision instruments for neurology, neurosurgery and neuroscience research | 1970 | fh-co.com | Bowdoinham, United States |
Investor details for Neuralynx
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Neuralynx
1 people are tracked at Neuralynx (1 in leadership); the tracked headcount is 17.
| Name | Role | Group |
|---|---|---|
Casey Stengel | Founder & President | Leadership |
Complete people profiles for Neuralynx
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Neuralynx
2 dated milestones of Neuralynx across 28 years, from founding to its latest funding, stage changes and deals.
- Founded Neuralynx is founded.
- Exit Acquired by FHC.
Competitors of Neuralynx
Neuralynx operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Cepheid, Esco Lifesciences, Beckman Coulter, Blackrock Neurotech and Fluidigm, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| cepheid.com | 1996 | Sunnyvale, United States | $19.1M | 1,299 | Developer of molecular diagnostic testing solutions | |
| escolifesciences.com | 1978 | Singapore | $400M | – | Manufacturer of biopharma equipment & IVF medical devices, and service provider for life science tools | |
| beckman.com | 1935 | Brea, United States | – | – | Provider of products for biomedical testing for R&D, diagnostic and commercial applications | |
| blackrockneurotech.com | 2008 | Salt Lake, United States | $22.37M | 127 | Medical devices for neurological therapies are developed. | |
| fluidigm.com | 1999 | San Francisco, United States | $40.53M | 205 | Instruments for life sciences research and applications are developed. | |
| waters.com | 1958 | Milford, United States | – | 9,341 | Provider of laboratory management system for researchers and clinicians | |
| bruker.com | 1960 | United States | – | 9,707 | Diversified research instrument systems are manufactured and supplied. | |
| sartorius.com | 1870 | Gottingen, Germany | – | 566 | Laboratory and biopharmaceutical equipment is developed for production processes. | |
| unchainedlabs.com | 2015 | Pleasanton, United States | $111M | – | Multiplex protein stability platform for biologics is developed. |
Detailed competitors of Neuralynx
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Neuralynx
The website of Neuralynx (neuralynx.com) receives about 2.4K visits a month.
- Monthly visits2.4K
▼ 9.1% vs previous month
Websites whose visitors overlap most with Neuralynx. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
corante.com | corante.com | 100% | – | – | – |
scientifica.uk.com | scientifica.uk.com | 94% | – | #1,077,420 | – |
jarvislab.net | jarvislab.net | 94% | – | #5,270,899 | – |
| heka.com | 58% | 5.3K | #3,456,042 | View details |
Similar companies to Neuralynx
10 companies that operate in the same segment as Neuralynx (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | – | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Neuralynx
Neuralynx was founded in 1993.
Neuralynx is headquartered in Bozeman, United States. It is registered at Bozeman, Montana, United States.
Neuralynx has 17 employees.
Neuralynx was established in 1993 in Bozeman, United States, within the neuroscience sector. Electrophysiology research is supported through the ATLAS Neurophysiology System, designed for detecting and examining epileptic signals. Hardware and software components are integrated for data acquisition and neural signal measurement. Animal interface devices are supplied to facilitate experimental operations in laboratory settings.
Neuralynx's top competitors include Cepheid, Blackrock Neurotech and Esco Lifesciences.
Neuralynx offers Digital Lynx +, Research Software, and ATLAS Neurophysiology System.
Neuralynx has 1 investor. Key investors include FHC.
Neuralynx operates through Neuralynx, Inc..
Yes. Neuralynx was acquired by FHC in December 2021.